We are excited to invite you to our upcoming webinar, Strategic SmPC Optimization as the Core of EU JCA: Crafting a Blueprint for Market Access Success, presented by International Market Access Consulting (IMAC). This engaging session is scheduled for October 29th at 16:00 PM CEST (GMT+2), and we hope you will join us to gain valuable insights into how the development of the Summary of Product Characteristics (SmPC) may influence strategy for the European Joint Clinical Assessment (JCA).
The webinar will be led by IMAC's founder and CEO,
Louise Perrault, a recognized authority in
market access consulting. With decades of experience as an executive in the pharmaceutical industry and as a senior consultant, Louise established IMAC to provide expert market access solutions. Since 2006, IMAC has been dedicated to improving patient outcomes by helping clients navigate the complexities of market access for specialized therapies. Our team, driven by integrity and innovation, has collaborated with numerous partners to bring highly specialized technologies to targeted patient populations.
